Stimulation of acetilcholine (ACh) output from isolated brain slices by anticholinergic drugs: influence of septal lesion, changes in ionic environment and GABA.

P. Mantovani,P. Santicioli,G. Conte,G. Pepeu

DOI: https://doi.org/10.1016/S0031-6989(80)80147-0

1980-06-01

Pharmacological Research Communications

Abstract:

What problem does this paper attempt to address?

Emergency myelopoiesis distinguishes multisystem inflammatory syndrome in children from pediatric severe COVID-19

Katerina Roznik,Temesgen E Andargie,T Scott Johnston,Oren Gordon,Yi Wang,Nadine Peart Akindele,Deborah Persaud,Annukka A R Antar,Yukari C Manabe,Weiqiang Zhou,Hongkai Ji,Sean Agbor-Enoh,Andrew H Karaba,Elizabeth A Thompson,Andrea L Cox

DOI: https://doi.org/10.1093/infdis/jiae032

2024-02-02

The Journal of Infectious Diseases

Abstract:Background Multisystem inflammatory syndrome in children (MIS-C) is a hyperinflammatory condition caused by recent SARS-CoV-2 infection, but the underlying immunological mechanisms driving this distinct syndrome are unknown. Methods We utilized high dimensional flow cytometry, cell-free (cf) DNA, and cytokine and chemokine profiling to identify mechanisms of critical illness distinguishing MIS-C from severe acute COVID-19 (SAC). Results Compared to SAC, MIS-C patients demonstrated profound innate immune cell death and features of emergency myelopoiesis (EM), an understudied phenomenon observed in severe inflammation. EM signatures were characterized by fewer mature myeloid cells in the periphery and decreased expression of HLA-DR and CD86 on antigen presenting cells. IL-27, a cytokine known to drive hematopoietic stem cells towards EM, was increased in MIS-C, and correlated with immature cell signatures in MIS-C. Upon recovery, EM signatures decreased, and IL-27 plasma levels returned to normal levels. Despite profound lymphopenia, we report a lack of cfDNA released by adaptive immune cells and increased CCR7 expression on T cells indicative of egress out of peripheral blood. Conclusions Immune cell signatures of EM combined with elevated innate immune cell-derived cfDNA levels distinguish MIS-C from SAC in children and provide mechanistic insight into dysregulated immunity contributing towards MIS-C, offering potential diagnostic and therapeutic targets.

immunology,infectious diseases,microbiology
Deep immune profiling uncovers novel associations with clinical phenotypes of Multisystem Inflammatory Syndrome in Children (MIS-C)

Christopher Redmond,Moses M Kitakule,Aran Son,McKella Sylvester,Keith Sacco,Ottavia Delmonte,Francesco Licciardi,Riccardo Castagnoli,Cecilia Poli,Yasmin Espinoza,Camila Astudillo,Sarah E Weber,Gina A Montealegre Sanchez,Karyl Barron,Mary Magliocco,Kerry Dobbs,Yu Zhang,Helen Matthews,Cihan Oguz,Helen C Su,Luigi D Notarangelo,Pamela A Frischmeyer-Guerrerio,Daniella M Schwartz

DOI: https://doi.org/10.1101/2022.08.31.22279265

2022-09-02

MedRxiv

Abstract:Multisystem Inflammatory Syndrome in Children (MIS-C) is a systemic inflammatory condition that follows SARS-CoV2 infection or exposure in children. Clinical presentations are highly variable and include fever, gastrointestinal (GI) disease, shock, and Kawasaki Disease-like illness (MIS-C/KD). Compared to patients with acute COVID, patients with MIS-C have a distinct immune signature and expansion of TRVB11 expressing T cells. However, the relationship between immunological and clinical phenotypes of MIS-C is unknown. Here, we measured serum biomarkers, TCR repertoire, and SARS-CoV2-specific T cell responses in a cohort of 76 MIS-C patients. Serum biomarkers associated with macrophage and Th1 activation were elevated in patients with shock, consistent with previous reports. Significantly increased SARS-CoV-2-induced IFN-γ, IL-2, and TNF-α production were seen in CD4 + T cells from patients with neurologic involvement and respiratory failure. Diarrhea was associated with a significant reduction in shock-associated serum biomarkers, suggesting a protective effect. TRVB11 usage was highly associated with MIS-C/KD and coronary aneurysms, suggesting a potential biomarker for these manifestations in MIS-C patients. By identifying novel immunologic associations with the different clinical phenotypes of MIS-C, this study provides insights into the clinical heterogeneity of MIS-C. These unique immunophenotypic associations could provide biomarkers to identify patients at risk for severe complications of MIS-C, including shock and MIS-C/KD.
Antibody-mediated cellular responses are dysregulated in Multisystem Inflammatory Syndrome in Children (MIS-C)

Jenna K Dick,Jules A Sangala,Venkatramana D Krishna,Aaron Khaimraj,Lydia Hamel,Spencer M Erickson,Dustin Hicks,Yvette Soigner,Laura E Covill,Alexander K Johnson,Michael J Ehrhardt,Keenan Ernste,Petter Brodin,Richard A Koup,Alka Khaitan,Carly Baehr,Beth K Thielen,Christine M Henzler,Caleb Skipper,Jeffrey S Miller,Yenan T Bryceson,Jianming Wu,Chandy C John,Angela Panoskaltsis-Mortari,Alberto Orioles,Marie E Steiner,Maxim C-J Cheeran,Marco Pravetoni,Geoffrey T Hart

DOI: https://doi.org/10.1093/jpids/piae093.025

2024-11-04

Journal of the Pediatric Infectious Diseases Society

Abstract:BackgroundMultisystem Inflammatory Syndrome in Children (MIS-C) is a rare and severe complication of SARS-CoV-2 infection that is characterized by multi-organ involvement and substantial inflammation. The immunological responses in MIS-C are not fully known. Antibody-mediated viral clearance in which innate immune cells interact with antibodies via their Fc receptors to remove the virus is an important mechanism for reducing SARS-CoV-2 viral load. However, little is known about how antibody-mediated cellular responses in MIS-C compared to acute COVID-19 infection and direct testing of cellular function ex vivo to understand the aberrant immune response in MIS-C is limited. Therefore, we focused on the antibody-mediated cellular responses in MIS-C relative to children and adults that had acute COVID-19 infection with spectrum of symptoms. We hypothesized that cells that bind antibodies to help clear the virus are dysfunctional in MIS-C patients, preventing the virus from being fully cleared.MethodsWe collected samples from MIS-C children along with pediatric and adult subjects with a clinical spectrum of COVID-19 symptoms and uninfected controls. Through these controls, we can compare Fc-mediated antibody functions between ages and clinical symptoms. We utilized high dimension flow cytometry to assess phenotype and function of innate immune cells that bind to antibodies and sequencing to study Fc receptor genetic. This data was then correlated with matched clinical data.ResultsMonocytes in MIS-C were hyperfunctional for antibody-dependent cellular phagocytosis and production of proinflammatory cytokines. In contrast, natural killer (NK) cells in MIS-C were hypofunctional for antibody-dependent cellular cytotoxicity and cytokine production. To provide some preliminary insight into mechanism, we show multiple ways leading to decreased cytotoxicity for NK cells, including phenotypic exhaustion of NK cells, variants in CD16 (NK cell Fc receptor) genetics that reduce Fc binding to IgG, and cytokine-induced associations. Using a novel anti-CD16 novel bispecific reagent that we developed, we could rescue the hypofunctional antibody-mediated NK cell function in MIS-C to the same levels as control.ConclusionTogether, our results reveal dysregulation in antibody-mediated responses that are unique to MIS-C and may contribute to the immune pathology of this disease. Specifically, we find that monocytes are hyperfunctional with NK cells are hypofunctional. In the case of the MIS-C antibody-mediated response, while it is likely that multiple pathogenetic mechanisms contribute to MIS-C, our data suggest an imbalance of the antibody-mediated cellular response as a mechanistic correlate of this rare, but life-threatening outcome of SARS-COV-2 in children. Our results highlight that targeted therapies to reduce viral burden and/or boost NK cells responses while decreasing cytokine levels may be effective in preventing MIS-C.

pediatrics,infectious diseases
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

Keith Sacco,Riccardo Castagnoli,Svetlana Vakkilainen,Can Liu,Ottavia M. Delmonte,Cihan Oguz,Ian M. Kaplan,Sara Alehashemi,Peter D. Burbelo,Farzana Bhuyan,Adriana A. de Jesus,Kerry Dobbs,Lindsey B. Rosen,Aristine Cheng,Elana Shaw,Mikko S. Vakkilainen,Francesca Pala,Justin Lack,Yu Zhang,Danielle L. Fink,Vasileios Oikonomou,Andrew L. Snow,Clifton L. Dalgard,Jinguo Chen,Brian A. Sellers,Gina A. Montealegre Sanchez,Karyl Barron,Emma Rey-Jurado,Cecilia Vial,Maria Cecilia Poli,Amelia Licari,Daniela Montagna,Gian Luigi Marseglia,Francesco Licciardi,Ugo Ramenghi,Valentina Discepolo,Andrea Lo Vecchio,Alfredo Guarino,Eli M. Eisenstein,Luisa Imberti,Alessandra Sottini,Andrea Biondi,Sayonara Mató,Dana Gerstbacher,Meng Truong,Michael A. Stack,Mary Magliocco,Marita Bosticardo,Tomoki Kawai,Jeffrey J. Danielson,Tyler Hulett,Manor Askenazi,Shaohui Hu,Jeffrey I. Cohen,Helen C. Su,Douglas B. Kuhns,Michail S. Lionakis,Thomas M. Snyder,Steven M. Holland,Raphaela Goldbach-Mansky,John S. Tsang,Luigi D. Notarangelo,Jason Barnett,Xi Cheng,Krishnaveni Kaladi,Vasudev Kuram,Joseph Mackey,Neha M. Bansal,Andrew J. Martins,Boaz Palterer,Helen Matthews,Uma Mudunuri,Marshall Nambiar,Andrew J. Oler,Andre Rastegar,Smilee Samuel,Conrad Shyu,Varsha Waingankar,Sarah Weber,Sandhya Xirasagar,Yazmin Espinosa,Camila Astudillo,Cecilia Piñera,Ricardo González,Maria De Filippo,Martina Votto,Lorenza Montagna,,,

DOI: https://doi.org/10.1038/s41591-022-01724-3

IF: 82.9

2022-02-17

Nature Medicine

Abstract:Pediatric Coronavirus Disease 2019 (pCOVID-19) is rarely severe; however, a minority of children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might develop multisystem inflammatory syndrome in children (MIS-C), with substantial morbidity. In this longitudinal multi-institutional study, we applied multi-omics (analysis of soluble biomarkers, proteomics, single-cell gene expression and immune repertoire analysis) to profile children with COVID-19 (n = 110) and MIS-C (n = 76), along with pediatric healthy controls (pHCs; n = 76). pCOVID-19 was characterized by robust type I interferon (IFN) responses, whereas prominent type II IFN-dependent and NF-κB-dependent signatures, matrisome activation and increased levels of circulating spike protein were detected in MIS-C, with no correlation with SARS-CoV-2 PCR status around the time of admission. Transient expansion of TRBV11-2 T cell clonotypes in MIS-C was associated with signatures of inflammation and T cell activation. The association of MIS-C with the combination of HLA A*02, B*35 and C*04 alleles suggests genetic susceptibility. MIS-C B cells showed higher mutation load than pCOVID-19 and pHC. These results identify distinct immunopathological signatures in pCOVID-19 and MIS-C that might help better define the pathophysiology of these disorders and guide therapy.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Innate immune dysregulation in multisystem inflammatory syndrome in children (MIS-C)

Johana Isaza-Correa,Laura Ryan,Lynne Kelly,John Allen,Ashanty Melo,Jennifer Jones,Dean Huggard,Emer Ryan,Cilian Ó Maoldomhnaigh,Sarah Geoghehan,Patrick Gavin,Timothy Ronan Leahy,Karina Butler,Bridget Freyne,Eleanor J. Molloy

DOI: https://doi.org/10.1038/s41598-023-43390-6

IF: 4.6

2023-10-02

Scientific Reports

Abstract:MIS-C is a systemic inflammation disorder with poorly characterised immunopathological mechanisms. We compared changes in the systemic immune response in children with MIS-C (n = 12, 5–13 years) to healthy controls (n = 14, 5–15 years). Analysis was done in whole blood treated with LPS. Expression of CD11b and Toll-like receptor-4 (TLR4) in neutrophils and monocytes were analysed by flow cytometry. Serum cytokines (IL-1β, IL-2, IL-6, IL-8, IL-10, IL-Ira, TNF-α, TNF-β, IFN-Υ, VEGF, EPO and GM-CSF) and mRNA levels of inflammasome molecules (NLRP3, ASC and IL-1β) were evaluated. Subpopulations of lymphocytes (CD3 + , CD19 + , CD56 + , CD4 + , CD8 + , TCR Vδ1 + , TCR Vδ2 + ) were assessed at basal levels. Absolute counts of neutrophils and NLR were high in children with MIS-C while absolute counts of lymphocytes were low. Children with MIS-C had increased levels of IL-6, IL-10, TNF-β and VEGF serum cytokines at the basal level, and significantly increased TNF-β post-LPS, compared to controls. IL-1RA and EPO decreased at baseline and post-LPS in MIS-C patients compared to controls. The percentage of CD3 + cells, NK cells and Vδ1 was lower while B cells were higher in children with MIS-C than in controls. Dysregulated immune response in children with MIS-C was evident and may be amenable to immunomodulation.

multidisciplinary sciences
NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children

Jenna K Dick,Jules A Sangala,Venkatramana D Krishna,Aaron Khaimraj,Lydia Hamel,Spencer M Erickson,Dustin Hicks,Yvette Soigner,Laura E Covill,Alexander K Johnson,Michael J Ehrhardt,Keenan Ernste,Petter Brodin,Richard A Koup,Alka Khaitan,Carly Baehr,Beth K Thielen,Christine M Henzler,Caleb Skipper,Jeffrey S Miller,Yenan T Bryceson,Jianming Wu,Chandy C John,Angela Panoskaltsis-Mortari,Alberto Orioles,Marie E Steiner,Maxim C J Cheeran,Marco Pravetoni,Geoffrey T Hart

DOI: https://doi.org/10.4049/jimmunol.2400395

2024-11-15

Abstract:Multisystem inflammatory syndrome in children (MIS-C) is a severe complication of SARS-CoV-2 infection characterized by multiorgan involvement and inflammation. Testing of cellular function ex vivo to understand the aberrant immune response in MIS-C is limited. Despite strong Ab production in MIS-C, SARS-CoV-2 nucleic acid testing can remain positive for 4-6 wk postinfection. Therefore, we hypothesized that dysfunctional cell-mediated Ab responses downstream of Ab production may be responsible for delayed clearance of viral products in MIS-C. In MIS-C, monocytes were hyperfunctional for phagocytosis and cytokine production, whereas NK cells were hypofunctional for both killing and cytokine production. The decreased NK cell cytotoxicity correlated with an NK exhaustion marker signature and systemic IL-6 levels. Potentially providing a therapeutic option, cellular engagers of CD16 and SARS-CoV-2 proteins were found to rescue NK cell function in vitro. Taken together, our results reveal dysregulation in Ab-mediated cellular responses of myeloid and NK cells that likely contribute to the immune pathology of this disease.
Molecular mimicry in multisystem inflammatory syndrome in children

Aaron Bodansky,Robert C Mettelman,Joseph J Sabatino Jr,Sara E Vazquez,Janet Chou,Tanya Novak,Kristin L Moffitt,Haleigh S Miller,Andrew F Kung,Elze Rackaityte,Colin R Zamecnik,Jayant V Rajan,Hannah Kortbawi,Caleigh Mandel-Brehm,Anthea Mitchell,Chung-Yu Wang,Aditi Saxena,Kelsey Zorn,David J L Yu,Mikhail V Pogorelyy,Walid Awad,Allison M Kirk,James Asaki,John V Pluvinage,Michael R Wilson,Laura D Zambrano,Angela P Campbell,Overcoming COVID-19 Network Investigators,Paul G Thomas,Adrienne G Randolph,Mark S Anderson,Joseph L DeRisi,Laura L Loftis,Charlotte V Hobbs,Keiko M Tarquinio,Michele Kong,Julie C Fitzgerald,Paula S Espinal,Tracie C Walker,Stephanie P Schwartz,Hillary Crandall,Katherine Irby,Mary Allen Staat,Courtney M Rowan,Jennifer E Schuster,Natasha B Halasa,Shira J Gertz,Elizabeth H Mack,Aline B Maddux,Natalie Z Cvijanovich,Matt S Zinter

DOI: https://doi.org/10.1038/s41586-024-07722-4

IF: 64.8

Nature

Abstract:Multisystem inflammatory syndrome in children (MIS-C) is a severe, post-infectious sequela of SARS-CoV-2 infection1,2, yet the pathophysiological mechanism connecting the infection to the broad inflammatory syndrome remains unknown. Here we leveraged a large set of samples from patients with MIS-C to identify a distinct set of host proteins targeted by patient autoantibodies including a particular autoreactive epitope within SNX8, a protein involved in regulating an antiviral pathway associated with MIS-C pathogenesis. In parallel, we also probed antibody responses from patients with MIS-C to the complete SARS-CoV-2 proteome and found enriched reactivity against a distinct domain of the SARS-CoV-2 nucleocapsid protein. The immunogenic regions of the viral nucleocapsid and host SNX8 proteins bear remarkable sequence similarity. Consequently, we found that many children with anti-SNX8 autoantibodies also have cross-reactive T cells engaging both the SNX8 and the SARS-CoV-2 nucleocapsid protein epitopes. Together, these findings suggest that patients with MIS-C develop a characteristic immune response to the SARS-CoV-2 nucleocapsid protein that is associated with cross-reactivity to the self-protein SNX8, demonstrating a mechanistic link between the infection and the inflammatory syndrome, with implications for better understanding a range of post-infectious autoinflammatory diseases.
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

Mary Beth F. Son,Nancy Murray,Kevin Friedman,Cameron C. Young,Margaret M. Newhams,Leora R. Feldstein,Laura L. Loftis,Keiko M. Tarquinio,Aalok R. Singh,Sabrina M. Heidemann,Vijaya L. Soma,Becky J. Riggs,Julie C. Fitzgerald,Michele Kong,Sule Doymaz,John S. Giuliano,Michael A. Keenaghan,Janet R. Hume,Charlotte V. Hobbs,Jennifer E. Schuster,Katharine N. Clouser,Mark W. Hall,Lincoln S. Smith,Steven M. Horwitz,Stephanie P. Schwartz,Katherine Irby,Tamara T. Bradford,Aline B. Maddux,Christopher J. Babbitt,Courtney M. Rowan,Gwenn E. McLaughlin,Phoebe H. Yager,Mia Maamari,Elizabeth H. Mack,Christopher L. Carroll,Vicki L. Montgomery,Natasha B. Halasa,Natalie Z. Cvijanovich,Bria M. Coates,Charles E. Rose,Jane W. Newburger,Manish M. Patel,Adrienne G. Randolph

DOI: https://doi.org/10.1056/NEJMoa2102605

2021-06-18

Abstract:In the spring of 2020, the rapid emergence of multisystem inflammatory syndrome in children (MIS-C) 1-3 — a presumed postinfectious complication of coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) — necessitated decisions regarding immunomodulatory treatment without an evidence base or an understanding of its pathophysiological characteristics. Patients with MIS-C had prominent cardiovascular involvement, including shock, echocardiographic findings of decreased function, and coronary-artery aneurysms, for which they received urgent intervention. 4 Given the similarities between MIS-C and Kawasaki's disease, a vasculitis of childhood that can cause coronary-artery aneurysms and sometimes a shock-like presentation, 5 most patients with MIS-C were treated with intravenous immune globulin (IVIG), 6 the standard treatment for Kawasaki's disease. 7 Although contemporaneous studies showed clinical and immunophenotypic differences between Kawasaki's disease and MIS-C, 8-10 findings of myocarditis in many patients with MIS-C also supported treatment with IVIG, given its use in clinical practice for viral myocarditis. 11,12 Features of cytokine storm led to the use of dexamethasone in patients with acute Covid-19, 13 and the frequent concurrent finding of a severe shock-like presentation in patients with MIS-C 14 probably encouraged the use of glucocorticoids, in varying doses. 15
Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children

Zhenguang Zhang,Iain R L Kean,Lisa M Dratva,John A Clark,Eleni Syrimi,Naeem Khan,Esther Daubney,Deborah White,Lauran O'Neill,Catherine Chisholm,Caroline Payne,Sarah Benkenstein,Klaudia Kupiec,Rachel Galassini,Victoria Wright,Helen Winmill,Ceri Robbins,Katherine Brown,Padmanabhan Ramnarayan,Barnaby Scholefield,Mark Peters,Nigel Klein,Hugh Montgomery,Kerstin B Meyer,Sarah A Teichmann,Clare Bryant,Graham Taylor,Nazima Pathan

DOI: https://doi.org/10.1038/s41467-024-48699-y

2024-05-18

Abstract:Multisystem inflammatory syndrome in children is a post-infectious presentation SARS-CoV-2 associated with expansion of the T cell receptor Vβ21.3+ T-cell subgroup. Here we apply muti-single cell omics to compare the inflammatory process in children with acute respiratory COVID-19 and those presenting with non SARS-CoV-2 infections in children. Here we show that in Multi-Inflammatory Syndrome in Children (MIS-C), the natural killer cell and monocyte population demonstrate heightened CD95 (Fas) and Interleuking 18 receptor expression. Additionally, TCR Vβ21.3+ CD4+ T-cells exhibit skewed differentiation towards T helper 1, 17 and regulatory T cells, with increased expression of the co-stimulation receptors ICOS, CD28 and interleukin 18 receptor. We observe no functional evidence for NLRP3 inflammasome pathway overactivation, though MIS-C monocytes show elevated active caspase 8. This, coupled with raised IL18 mRNA expression in CD16- NK cells on single cell RNA sequencing analysis, suggests interleukin 18 and CD95 signalling may trigger activation of TCR Vβ21.3+ T-cells in MIS-C, driven by increased IL-18 production from activated monocytes and CD16- Natural Killer cells.
Alteration of murine odontogenic patterning and prolongation of expression of epidermal growth factor mRNA by retinol in vitro.

J. Kronmiller,W. B. Upholt,E. Kollar

DOI: https://doi.org/10.1016/0003-9969(92)90008-V

IF: 2.64

1992-02-01

Archives of Oral Biology

Abstract:
Myeloid-derived suppressor cells and T cell populations in children with Multisystem Inflammatory Syndrome

Katherine E Bline,Anna L Wilt,Robin N Alexander,Angel N Andrews,Sara E Mertz,Fang Ye,Lisa M Steele,Amber L Wolfe,Asuncion Mejias,Octavio Ramilo

DOI: https://doi.org/10.1038/s41390-023-02919-1

Abstract:Background: Multisystem inflammatory syndrome in children (MIS-C) represents a hyperinflammatory state that can result in multi-organ dysfunction and death. Myeloid-derived suppressor cells (MDSC) are an immunosuppressive cell population that expands under inflammatory conditions and suppresses T cell function. We hypothesized that MDSC would be increased in children with MIS-C and that MDSC expansion would be associated with T cell lymphopenia. Methods: We conducted a prospective, observational study. Initial blood samples were collected within 48 h of admission. Age-matched healthy controls underwent sampling once. MDSC and T cell populations were identified by flow cytometric methods. Results: We enrolled 22 children with MIS-C (12 ICU, 10 ward) and 21 healthy controls (HC). Children with MIS-C demonstrated significantly higher MDSC compared to HC, and MDSC expansion persisted for >3 weeks in the ICU group. Children with MIS-C admitted to the ICU demonstrated significantly lower absolute numbers of T cells and natural killer cells. There were no significant associations between MDSC and cardiac dysfunction, duration of hospitalization, or vasoactive inotrope score. Conclusions: Our study suggests that children critically ill with MIS-C have expansion of MDSC and associated decreased T cell and NK cell populations. Our results did not demonstrate associations between MDSC and clinical outcomes. Impact: Multisystem inflammatory syndrome in children (MIS-C) is a dysregulated immune response occurring several weeks after SARS-CoV-2 infection that can result in multi-organ dysfunction and death. Children severely ill with MIS-C demonstrated increased myeloid-derived suppressor cells and decreased absolute numbers of CD4+ and CD8 + T cells and NK cells compared to healthy controls. There was no significant association between MDSC numbers and clinical outcomes; including cardiac dysfunction, length of stay, or requirement of vasoactive support, in children with MIS-C.
[Anti-tumor effect of monkshood polysaccharide with adriamycin long circulating temperature-sensitive liposome and its mechanism].

Lan-feng Dong,Ying-jun Zhang,Jing-sheng Liu,Shu-xia Song,J. Hou,Zhan-jun Lu

2006-07-01

Abstract:AIM To observe the synergic action of monkshood polysaccharide (MPS) and adriamycin (ADM) long circulating temperature-sensitive liposome (ALTSL) in targeting therapy for H22 tumor-bearing mice and explore the mechanism. METHODS The anti-tumor activity was evaluated by using the tumor's weight as an index. The life prolongation rate of mice was calculated according to the survival time of the tumor-bearing mice. The killer activity of NK cells and the lymphocyte transformation rate were detected by the LDH release assay and MTT colorimetry, respectively. The apoptosis of tumor cells and the expressions of p53, Fas, Fas-L and caspase-3 were analyzed by flow cytometry. The expressions of IL-2 mRNA and IL-12 mRNA in spleen lymphocytes were determined by RT-PCR. The pathologic changes of tumor, heart, liver and kidney tissues of the tumor-bearing mice were observed under light microscope. RESULTS Compared with the adriamycin liposome group, the anti-tumor effects were enhanced in (MPS+ALTSL) group with tumor growth inhibitory rate up to 80.4%. The survival time of the tumor-bearing mice in ALTSL and (MPS+ALTSL) groups was significantly prolonged compared with the ADM group (P<0.01). The killer activity of NK cells was higher in ALTSL group than in the NS and ADM groups, and was highest in (MPS+ALTSL) group. The lymphocyte transformation rate of (MPS+ALTSL) group was markedly increased (P<0.01) as compared with the ADM group. The result of RT-PCR indicated that the expressions of IL-2 mRNA and IL-12 mRNA in lymphocytes in the adriamycin long circulating liposome (ALCL) group were significantly higher than those in the ADM group. Expressions of IL-2 mRNA and IL-12 mRNA was much higher in (MPS+ALTSL) group than in ALTSL group. The pathological examination indicated that in (MPS+ALTSL) group, more lymphocytes and monocytes were found in tumor tissue. CONCLUSION ALTSL can increase the anti-tumor effect and decrease the side-effects (such as the cytotoxicity) of ADM. MPS combined with ALTSL can enhance killer activity of NK cells and transformation of T cells, supporting their synergic anti-tumor effect.
MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity

Monica Gelzo,Alice Castaldo,Antonietta Giannattasio,Giulia Scalia,Maddalena Raia,Maria Valeria Esposito,Marco Maglione,Stefania Muzzica,Carolina D'Anna,Michela Grieco,Vincenzo Tipo,Antonio La Cava,Giuseppe Castaldo

DOI: https://doi.org/10.3389/fimmu.2022.985433

2022-10-03

Abstract:Multisystem inflammatory syndrome in children (MIS-C) is a rare, severe complication of COVID-19. A better knowledge of immunological, cellular, and genetic characteristics of MIS-C could help better understand the pathogenesis of the disease and contribute to identifying specific diagnostic biomarkers and develop targeted therapies. We studied 37 MIS-C children at hospital admission and 24 healthy controls analyzing serum cytokines (IFN-α, IFN-β, IFN-γ, IL-6, IL-10, IL-17A, IL-12p70 and TNF), lymphocyte populations by flow cytometry and 386 genes related to autoimmune diseases, autoinflammation and primary immunodeficiencies by NGS. MIS-C patients showed a significant increase of serum IFNγ (despite a significant reduction of activated Th1) and ILs, even if with a great heterogeneity among patients, revealing different pathways involved in MIS-C pathogenesis and suggesting that serum cytokines at admission may help to select the inflammatory pathways to target in each patient. Flow cytometry demonstrated a relevant reduction of T populations while the percentage of B cell was increased in agreement with an autoimmune pathogenesis of MIS-C. Genetic analysis identified variants in 34 genes and 83.3% of patients had at least one gene variant. Among these, 9 were mutated in more patients. Most genes are related to autoimmune diseases like ATM, NCF1, MCM4, FCN3, and DOCK8 or to autoinflammatory diseases associated to the release of IFNγ like PRF1, NOD2, and MEF. Thus, an incomplete clearance of the Sars-CoV2 during the acute phase may induce tissue damage and self-antigen exposure and genetic variants can predispose to hyper-reactive immune dysregulation events of MIS-C-syndrome. Type II IFN activation and cytokine responses (mainly IL-6 and IL-10) may cause a cytokine storm in some patients with a more severe acute phase of the disease, lymphopenia and multisystemic organ involvement. The timely identification of such patients with an immunocytometric panel might be critical for targeted therapeutic management.
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19

Camila Rosat Consiglio,Nicola Cotugno,Fabian Sardh,Christian Pou,Donato Amodio,Lucie Rodriguez,Ziyang Tan,Sonia Zicari,Alessandra Ruggiero,Giuseppe Rubens Pascucci,Veronica Santilli,Tessa Campbell,Yenan Bryceson,Daniel Eriksson,Jun Wang,Alessandra Marchesi,Tadepally Lakshmikanth,Andrea Campana,Alberto Villani,Paolo Rossi,the CACTUS Study Team,Nils Landegren,Paolo Palma,Petter Brodin

DOI: https://doi.org/10.1016/j.cell.2020.09.016

IF: 64.5

2020-11-01

Cell

Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is typically very mild and often asymptomatic in children. A complication is the rare multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, presenting 4–6 weeks after infection as high fever, organ dysfunction, and strongly elevated markers of inflammation. The pathogenesis is unclear but has overlapping features with Kawasaki disease suggestive of vasculitis and a likely autoimmune etiology. We apply systems-level analyses of blood immune cells, cytokines, and autoantibodies in healthy children, children with Kawasaki disease enrolled prior to COVID-19, children infected with SARS-CoV-2, and children presenting with MIS-C. We find that the inflammatory response in MIS-C differs from the cytokine storm of severe acute COVID-19, shares several features with Kawasaki disease, but also differs from this condition with respect to T cell subsets, interleukin (IL)-17A, and biomarkers associated with arterial damage. Finally, autoantibody profiling suggests multiple autoantibodies that could be involved in the pathogenesis of MIS-C.

cell biology,biochemistry & molecular biology
1093. Multiparametric Investigation Of Spike-Protein Specific T-cell Cytokine Expression Profile In Children With Symptomatic COVID-19 Or Multisystem Inflammatory Syndrome

Filippos Filippatos,Marianna Tzanoudaki,Elizabeth-Barbara Tatsi,Vasiliki Efthymiou,Manolis Liatsis,Vasiliki Syriopoulou,Athanasios Michos

DOI: https://doi.org/10.1093/ofid/ofac492.933

2022-12-01

Open Forum Infectious Diseases

Abstract:Abstract Background Data regarding cell-mediated immunological differences in children across COVID-19 clinical spectrum are limited. We prospectively investigated Spike-protein specific cellular immunity in children with symptomatic COVID-19 or MIS-C, by single cell cytokine expression profiling. Methods PBMCs from children with MIS-C, symptomatic COVID-19 (one month after hospitalization) and healthy controls were isolated prospectively. Cell suspensions were divided into two quantitatively equal samples (a negative control-unstimulated and a positive-stimulated). Cells stimulation was performed using SARS-CoV-2 Spike antigenic peptides mix (Peptivator SARS-CoV-2 Prot_S). Cells of each sample were stained with fluorochrome monoclonal antibodies against 8 surface markers (CD3, CD4, CD8, CD14, CD19, CD137, CD197, CD45RA) and 6 intracellular markers (IL-4, IL-2, IL-17, IFN-γ, TNF-α, Granzyme B). Viability was assessed by 7AAD. Stained cell preparations were analysed using 13 colour Flow Cytometry (DX Flex, Beckman Coulter). Flow cytometric analysis was performed using Kaluza 2.1 Software. Results Sixteen children (4 MIS-C, 8 post-COVID-19 and 4 healthy controls) were included in the study. The mean age (±SD) of the participants was 11.22 years (±3.48). Children with MIS-C had significantly higher mean (±SD) values of CD8+IFN-γ/million CD3+ [226.68 (134.92) vs 45.43 (57.28); P: 0.033] and median (IQR) of CD8+IFN-γ/ml [156.38 (184.13) vs 26.34 (82.36);P: 0.033] compared to symptomatic COVID-19 children. Compared to healthy controls, MIS-C patients had significantly higher median (IQR) values of CD4+IL-2/million CD3+ [923.12 (3777.95) vs 97.59 (71.71); P: 0.042] and CD4+IL-2/ml median (IQR) [626.33 (2744.98) vs 169.3 (173.91); P: 0.042]. No other significant differences were observed regarding other immunological markers in 3 study groups. Conclusion IFN-γ production by CD8+ T cells is highly expressed in children with MIS-C compared to hospitalized children one month after acute COVID-19 and could consist possible immunological biomarker. Further studies are needed in order to elucidate the pathophysiological basis of these findings. Disclosures All Authors: No reported disclosures.

immunology,infectious diseases,microbiology
Cytokine Profile in Children with Severe Multisystem Inflammatory Syndrome Related to the Coronavirus Disease 2019

Miguel Rodríguez-Rubio,Juan J. Menéndez-Suso,Carmen Cámara-Hijón,Miguel Río-García,María Laplaza-González,Irene Amores-Hernández,María P. Romero-Gómez,Elena Álvarez-Rojas,Diana Salas-Mera,Eduardo López-Granados,Pedro de la Oliva

DOI: https://doi.org/10.1055/s-0041-1724101

2021-02-24

Journal of Pediatric Intensive Care

Abstract:Abstract The multisystem inflammatory syndrome in children (MIS-C) is a novel and concerning entity related to severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. Although MIS-C has been the subject of intensive research efforts, its pathophysiology and optimal treatment remain elusive. We studied the clinical features, laboratory findings, and immunoinflammatory profiles of seven children prospectively admitted to a pediatric intensive care unit (PICU) during the first wave of the pandemic. All patients had immunoglobulin (Ig)-G against SARS-CoV-2, four of seven patients had both IgM and IgG, and in one of the 7 SARS-CoV-2 was detected in a respiratory sample. All patients received intravenous fluid boluses (median: 15 mL/kg) and norepinephrine. The most common form of respiratory support was supplemental oxygen via nasal cannula. None of the patients needed mechanical ventilation. The cardiovascular system was frequently involved. All patients had an elevated troponin-I (median: 107.3 ng/L). Four out of seven patients had coronary artery abnormalities, and two of seven had both abnormal electrocardiogram (EKG) findings and evidence of left ventricular dysfunction on echocardiogram. Ig levels and complement function were normal. Peripheral blood phenotyping with flow cytometry showed decreased T-cell numbers at the expense of CD8+ T-cells. Cytokine profiling showed a heterogeneous increase in interleukin (IL)-6, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, IL-18, IL-2Ra, IL-10, and IL-1Ra that tended to normalize after treatment. Our study shows that children with MIS-C have elevated plasma levels of pro- and anti-inflammatory cytokines in the acute phase of the disease without other relevant immunologic disturbances. These findings suggest the presence of a mixed antagonist response syndrome (MARS) similar to that present in pediatric sepsis. Combining a meticulous differential diagnosis with cautiously coordinated immunomodulatory therapy and high-quality supportive care can help clinicians avoid causing iatrogenic harm in patients with MIS-C.
Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children

Noam D. Beckmann,Phillip H. Comella,Esther Cheng,Lauren Lepow,Aviva G. Beckmann,Scott R. Tyler,Konstantinos Mouskas,Nicole W. Simons,Gabriel E. Hoffman,Nancy J. Francoeur,Diane Marie Del Valle,Gurpawan Kang,Anh Do,Emily Moya,Lillian Wilkins,Jessica Le Berichel,Christie Chang,Robert Marvin,Sharlene Calorossi,Alona Lansky,Laura Walker,Nancy Yi,Alex Yu,Jonathan Chung,Matthew Hartnett,Melody Eaton,Sandra Hatem,Hajra Jamal,Alara Akyatan,Alexandra Tabachnikova,Lora E. Liharska,Liam Cotter,Brian Fennessy,Akhil Vaid,Guillermo Barturen,Hardik Shah,Ying-chih Wang,Shwetha Hara Sridhar,Juan Soto,Swaroop Bose,Kent Madrid,Ethan Ellis,Elyze Merzier,Konstantinos Vlachos,Nataly Fishman,Manying Tin,Melissa Smith,Hui Xie,Manishkumar Patel,Kai Nie,Kimberly Argueta,Jocelyn Harris,Neha Karekar,Craig Batchelor,Jose Lacunza,Mahlet Yishak,Kevin Tuballes,Ieisha Scott,Arvind Kumar,Suraj Jaladanki,Charuta Agashe,Ryan Thompson,Evan Clark,Bojan Losic,Lauren Peters,Charuta Agashe,Priyal Agrawal,Eziwoma Alibo,Kelvin Alvarez,Angelo Amabile,Steven Ascolillo,Rasheed Bailey,Priya Begani,Cansu Cimen Bozkus,Paloma Bravo,Stacey-Ann Brown,Mark Buckup,Larissa Burka,Lena Cambron,Gina Carrara,Serena Chang,Steven T. Chen,Jonathan Chien,Mashkura Chowdhury,Dana Cosgrove,Francesca Cossarini,Arpit Dave,Travis Dawson,Bheesham Dayal,Maxime Dhainaut,Rebecca Dornfeld,Katie Dul,Nissan Eber,Frank Fabris,Jeremiah Faith,Dominique Falci,Susie Feng,Marie Fernandes,Daniel Geanon,Joanna Grabowska,Gavin Gyimesi,Maha Hamdani,Diana Handler,Manon Herbinet,Elva Herrera,Arielle Hochman,Jaime Hook,Laila Horta,Etienne Humblin,Jessica S. Johnson,Subha Karim,Geoffrey Kelly,Jong Kim,Dannielle Lebovitch,Brian Lee,Grace Lee,Gyu Ho Lee,Jacky Lee,John Leech,Michael B. Leventhal,Katherine Lindblad,Alexandra Livanos,Rosalie Machado,Zafar Mahmood,Kelcey Mar,Glenn Martin,Shrisha Maskey,Paul Matthews,Katherine Meckel,Saurabh Mehandru,Cynthia Mercedes,Dara Meyer,Gurkan Mollaoglu,Sarah Morris,Marjorie Nisenholtz,Merouane Ounadjela,Vishwendra Patel,Cassandra Pruitt,Shivani Rathi,Jamie Redes,Ivan Reyes-Torres,Alcina Rodrigues,Alfonso Rodriguez,Vladimir Roudko,Evelyn Ruiz,Pearl Scalzo,Alessandra Soares Schanoski,Pedro Silva,Hiyab Stefanos,Meghan Straw,Collin Teague,Bhaskar Upadhyaya,Verena Van Der Heide,Natalie Vaninov,Daniel Wacker,Hadley Walsh,C. Matthias Wilk,Jessica Wilson,Li Xue,Naa-akomaah Yeboah,Sabina Young,Nina Zaks,Renyuan Zha,Panagiotis Roussos,Jun Zhu,Wenhui Wang,Andrew Kasarskis,Benjamin S. Glicksberg,Girish Nadkarni,Dusan Bogunovic,Cordelia Elaiho,Sandeep Gangadharan,George Ofori-Amanfo,Kasey Alesso-Carra,Kenan Onel,Karen M. Wilson,Carmen Argmann,Supinda Bunyavanich,Marta E. Alarcón-Riquelme,Thomas U. Marron,Adeeb Rahman,Seunghee Kim-Schulze,Sacha Gnjatic,Bruce D. Gelb,Miriam Merad,Robert Sebra,Eric E. Schadt,Alexander W. Charney,

DOI: https://doi.org/10.1038/s41467-021-24981-1

IF: 16.6

2021-08-11

Nature Communications

Abstract:Abstract Multisystem inflammatory syndrome in children (MIS-C) presents with fever, inflammation and pathology of multiple organs in individuals under 21 years of age in the weeks following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Although an autoimmune pathogenesis has been proposed, the genes, pathways and cell types causal to this new disease remain unknown. Here we perform RNA sequencing of blood from patients with MIS-C and controls to find disease-associated genes clustered in a co-expression module annotated to CD56 dim CD57 + natural killer (NK) cells and exhausted CD8 + T cells. A similar transcriptome signature is replicated in an independent cohort of Kawasaki disease (KD), the related condition after which MIS-C was initially named. Probing a probabilistic causal network previously constructed from over 1,000 blood transcriptomes both validates the structure of this module and reveals nine key regulators, including TBX21, a central coordinator of exhausted CD8 + T cell differentiation. Together, this unbiased, transcriptome-wide survey implicates downregulation of NK cells and cytotoxic T cell exhaustion in the pathogenesis of MIS-C.

multidisciplinary sciences
Structural factors involved in the control of metabolism in ascites-tumor cells.

L. Packer,R. H. Golder

DOI: https://doi.org/10.1016/0006-3002(59)90589-X

Biochimica et Biophysica Acta

Abstract:
Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing

Roberta L. DeBiasi,Ashraf S. Harahsheh,Hemalatha Srinivasalu,Anita Krishnan,Matthew P. Sharron,Kavita Parikh,Karen Smith,Michael Bell,Drew Michael,Meghan Delaney,Joseph Campos,Eric Vilain,Jonathan LoTempio,Jaclyn N. Kline,Tova Ronis,Suvankar Majumdar,Eleanor Sadler,Susan R. Conway,Charles I. Berul,Sangeeta Sule,Rebeca Lahoz,Emily Ansusinha,Jay Pershad,Vanessa Bundy,Elizabeth Wells,James E. Bost,David Wessel,Children's National Hospital MIS-C Taskforce,Yasser Diab,Jessica Herstek,Sona Sehgal,Hemant Sharma,Andrea Hahn,Nada Harik,Rana Hamdy,Benjamin Hanisch,Barbara Jantausch,Adeline Koay,Bernhard Wiedermann,Alexandra Yonts,Xiaoyan Song,Jennifer Dien Bard

DOI: https://doi.org/10.1016/j.jpeds.2021.06.002

IF: 6.314

2021-10-01

The Journal of Pediatrics

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>To assess demographic, clinical, and biomarker features distinguishing patients with Multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Study design</h3><p>We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March-September 2020 at Children's National, a quaternary freestanding Children's Hospital in Washington DC. Of this cohort, 63 of the patients had the diagnosis of MIS-C (39 confirmed, 24 probable) and 61 were from the same cohort of admitted patients who subsequently had an alternative diagnosis (controls).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Median age and sex were similar between MIS-C and controls. Black (46%) and Latino (35%) children were overrepresented in the MIS-C cohort, with Black children at highest risk (OR 4.62, 95% CI 1.151-14.10; <em>P</em> = .007). Cardiac complications were more frequent in critically ill MIS-C (55% vs. 28%; p=0.04) including systolic myocardial dysfunction (39% vs. 3%; p=0.001), and valvular regurgitation (33% vs. 7%; p=0.01). Median cycle threshold (Ct) was 31.8 (27.95--35.1 IQR) in MIS-C cases, significantly higher (indicating lower viral load) than in primary SARS-CoV-2 infection. Cytokines siL2R, IL10, and IL-6 were higher in MIS-C compared with controls. Cytokine analysis revealed sub-phenotype differences between critically ill vs. noncritically ill (IL-2, sIL2R, IL-10, Il-6); PCR positive vs. negative (TNF-α, IL10, IL-6), and presence vs. absence of cardiac abnormalities (IL-17) Phylogenetic analysis of viral genome sequences revealed predominance of GH clade originating in Europe, with no differences comparing MIS-C with primary COVID patients. Treatment was well tolerated, and no children died.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>This study establishes a well-characterized large cohort of MIS-C treated following a standardized protocol and identifies key clinical, biomarker, cytokine, viral load, and sequencing features. Long term follow up will provide opportunity for future insights into MIS-C and its sequelae.</p>

pediatrics

Stimulation of acetilcholine (ACh) output from isolated brain slices by anticholinergic drugs: influence of septal lesion, changes in ionic environment and GABA.

Emergency myelopoiesis distinguishes multisystem inflammatory syndrome in children from pediatric severe COVID-19

Deep immune profiling uncovers novel associations with clinical phenotypes of Multisystem Inflammatory Syndrome in Children (MIS-C)

Antibody-mediated cellular responses are dysregulated in Multisystem Inflammatory Syndrome in Children (MIS-C)

Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

Innate immune dysregulation in multisystem inflammatory syndrome in children (MIS-C)

NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children

Molecular mimicry in multisystem inflammatory syndrome in children

Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children

Alteration of murine odontogenic patterning and prolongation of expression of epidermal growth factor mRNA by retinol in vitro.

Myeloid-derived suppressor cells and T cell populations in children with Multisystem Inflammatory Syndrome

[Anti-tumor effect of monkshood polysaccharide with adriamycin long circulating temperature-sensitive liposome and its mechanism].

MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity

The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19

1093. Multiparametric Investigation Of Spike-Protein Specific T-cell Cytokine Expression Profile In Children With Symptomatic COVID-19 Or Multisystem Inflammatory Syndrome

Cytokine Profile in Children with Severe Multisystem Inflammatory Syndrome Related to the Coronavirus Disease 2019

Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children

Structural factors involved in the control of metabolism in ascites-tumor cells.

Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing